FDA issues complete response letter for Cingulate's ADHD drug CTx-1301
Go back to FDA issues complete response letter for Cingulate's ADHD drug CTx-1301| (NASDAQ: CING) | Delayed: 4.52 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.52 | 52 Week High | $ | |||
| Open | $4.52 | 52 Week Low | $ | |||
| Day High | $4.52 | P/E | N/A | |||
| Day Low | $4.52 | EPS | $ | |||
| Volume | 750 | |||||
| (NASDAQ: CINGW) | Delayed: 0.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.02 | 52 Week High | $ | |||
| Open | $0.02 | 52 Week Low | $ | |||
| Day High | $0.02 | P/E | N/A | |||
| Day Low | $0.02 | EPS | $ | |||
| Volume | 624,575 | |||||

